Which hedge funds own AUPH? AURINIA PHARMACEUTICALS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
7 of the hedge funds tracked by WhaleCreep disclosed a position in AUPH (AURINIA PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $101.3m in total. The largest holder by portfolio weight is Renaissance Technologies LLC at 0.0% of its book. 1 exited: Tudor Investment.
7tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold AUPH? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $26.3m | 1,548,035 | -7% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $34.7m | 2,044,007 | 9% | added |
| Woodline Partners | Q2 2026 | 0.0% | $7.7m | 456,259 | 0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $23.9m | 1,408,456 | -10% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $420.3k | 24,770 | 4% | added |
| Millennium Management | Q2 2026 | 0.0% | $4.1m | 244,302 | 109% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $4.1m | 240,685 | -12% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Tudor Investment | 0.0% | $764.2k |
How has hedge fund ownership of AUPH changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 7 | $101.3m |
| Q1 2026 | 8 | $89.4m |
| Q4 2025 | 3 | $33.6m |
| Q3 2025 | 3 | $21.8m |
| Q2 2025 | 2 | $14.0m |
| Q1 2025 | 2 | $11.6m |
| Q4 2024 | 3 | $21.6m |
| Q3 2024 | 2 | $7.2m |
| Q2 2024 | 2 | $4.7m |
| Q1 2024 | 3 | $3.8m |
| Q4 2023 | 2 | $7.0m |
| Q3 2023 | 3 | $9.1m |
| Q2 2023 | 3 | $24.9m |
| Q1 2023 | 4 | $50.2m |
| Q4 2022 | 4 | $22.0m |
| Q3 2022 | 1 | $5.5m |
Counts every tracked manager that disclosed AUPH in that quarter's filing, including managers that have since stopped filing.